
Neu Health is a digital health company focused on making Parkinson's disease and dementia care accessible. Leveraging 10 years of research and clinical validation from the University of Oxford, their smartphone-based platform and patient program aim to improve outcomes for neurodegenerative conditions. The platform enables remote monitoring of patient symptoms, utilizing AI/ML analytics to predict clinical outcomes up to 18 months in advance. It also supports remote clinician-guided management, improved medication adherence, and provides reassurance and education for patients and carers. Neu Health supports individuals with Parkinson's and dementia, enabling them to live more independently.

Neu Health is a digital health company focused on making Parkinson's disease and dementia care accessible. Leveraging 10 years of research and clinical validation from the University of Oxford, their smartphone-based platform and patient program aim to improve outcomes for neurodegenerative conditions. The platform enables remote monitoring of patient symptoms, utilizing AI/ML analytics to predict clinical outcomes up to 18 months in advance. It also supports remote clinician-guided management, improved medication adherence, and provides reassurance and education for patients and carers. Neu Health supports individuals with Parkinson's and dementia, enabling them to live more independently.
Focus: Smartphone-based platform for Parkinson's disease and dementia care
Origin: Oxford University spinout (founded 2022) built on 10+ years of research
Clinical capability: At-home motor, speech, and cognitive assessments with AI/ML-derived digital biomarkers
Recent funding: Reported investments: $3.6M (2023) and ~$2.0M co-investment (Jan 2025)
Neurodegenerative disease care (Parkinson's disease and dementia)
2022
Digital health / Healthtech
$3.6M
Reported $3.6M investment announced October 2023
$2.0M
Co-investment announced to support U.S. expansion and a Cedars-Sinai pilot
“Backed by Oxford Science Enterprises; Cedars-Sinai participated as strategic co-investor in 2025”